Day: February 1, 2024

SAN DIEGO, CA, Feb. 01, 2024 (GLOBE NEWSWIRE) — via NewMediaWire –Sigyn Therapeutics, Inc. (“Sigyn” or the “Company”) (OTCQB: “SIGYD”, “SIGY”), a development-stage medical technology company, disclosed today that a 1-for-40 reverse split of its common stock was implemented on January 31, 2024.  As a result of the split, the Company’s common stock will trade under the ticker symbol “SIGYD” for 20 business days and subsequently revert to trading under its historic symbol “SIGY” on February 29, 2024. The post-split CUSIP number for the Company’s common stock is 82674U205. The Company also reported 1,221,043 its common shares to be issued and outstanding at the close of trading on January 31, 2024. About Sigyn Therapeutics™ Sigyn Therapeutics is a development-stage medical technology company headquartered in San Diego, California....

– Preliminary safety and efficacy data from ongoing LUNA Phase 2 study of Ixo-vec for the treatment of wet AMD will be presented at the 47th Annual Meeting of the Macula Society, with company-sponsored webcast on Thursday, February 8, 2024 at 8:00am ET – REDWOOD CITY, Calif., Feb. 01, 2024 (GLOBE NEWSWIRE) — Adverum Biotechnologies, Inc. (Nasdaq: ADVM), a clinical-stage company that aims to establish gene therapy as a new standard of care for highly prevalent ocular diseases, today announced that the company will host a webcast to review preliminary efficacy and safety data from its ongoing LUNA Phase 2 study of ixoberogene soroparvovec (Ixo-vec) for the treatment of wet age-related macular degeneration (wet AMD) on Thursday, February 8th, 2024 at 8:00am ET. The webcast will include Szilard Kiss, M.D., Professor of...

KING OF PRUSSIA, Pa., Feb. 01, 2024 (GLOBE NEWSWIRE) — Vertex, Inc. (NASDAQ:VERX), a leading global technology provider of indirect tax solutions, today announced that it will release fourth quarter 2023 financial results before the market opens on Thursday, February 29, 2023. A conference call to discuss the results will be held at 8:30 a.m. Eastern Time that same day. Those wishing to participate may do so by dialing 1-412-317-6026 approximately ten minutes prior to start time. A listen-only webcast of the call will also be available through the Company’s Investor Relations website at https://ir.vertexinc.com. A conference call replay will be available approximately one hour after the call by dialing 1-412-317-6671 and referencing passcode 10185697, or via the Company’s Investor Relations website. The replay will expire on March...

Urges Stockholders to Wait to Receive the Company’s Definitive Proxy Statement and WHITE Proxy Card Issues Open Letter to Focused Compounding PINE MOUNTAIN, Georgia, Feb. 01, 2024 (GLOBE NEWSWIRE) — Parks! America, Inc. (OTCPink: PRKA) (the “Company”) announced today that it has filed its preliminary proxy statement with the U.S. Securities and Exchange Commission (“SEC”) in connection with its Special Meeting of Stockholders (the “Special Meeting”) to be held February 26, 2024. The Company urges stockholders to wait to receive its definitive proxy statement and WHITE Proxy Card in the mail prior to determining how to vote at the Special Meeting. The Company also issued an open letter to Focused Compounding Fund, LP (collectively with its affiliates “Focused Compounding”). The full text of the letter follows. Dear Focused Compounding, As...

GUELPH, Ontario, Feb. 01, 2024 (GLOBE NEWSWIRE) — Hammond Power Solutions Inc. (“HPS” or the “Company”) (TSX: HPS.A) today announced the appointment of Mr. John Bailey as Chief Operations Officer (“COO”) effective as of January 1, 2024, who will succeed Mr. Bohdan (Bob) Yusyp who is expected to be retiring in April 2024. “Over the past 15 years, John has grown his career in operations directly under Bob’s mentorship,” said Adrian Thomas, Chief Executive Officer of HPS. “During that time, John has built significant experience working with our clients and strategically planning our operations to meet future demand. From his early days at HPS in production and planning, John quickly progressed to more senior roles, leading special projects such as system conversions, plant start-ups and expansions, successfully reaching the role of...